ACC 2011: MAGELLAN

Updated:Apr 6,2011
ACC11_Header2
MAGELLAN
Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
Alexander T. Cohen, MD, Bayer HealthCare AG, Leverkusen, Germany
acc11_MAGELLAN_image

ACC 2011: MAGELLAN Video


 








ACC 2011: Navigation

Science News from ACC 2011 - Home
Sunday, April 3
PARTNERPARTNER Cohort B
 
Monday, April 4
PRECOMBAT
EVEREST II
STICH
STICH Viability
RAPS
ISAR-CABG
RIVAL
RESOLUTE US
PLATINUM
REMEDIAL II
 
Tuesday, April 5
MAGELLAN
OSCAR
NAGOYA HEART Study
PROTECTION-AMI
EXCELLENT
 
TARGET Study
Rheos Trial
PROACT
AF Clinic
Danish Heart Failure Study
 
Science News Videos
Click on the link below to view complete video coverage from ACC 2011.  Plus, search all AHA/ASA Science news video archives.

acc11_sn_youtube2_button
 



 
SS11_ICT_Image

Don't Miss: Interventional Cardiology Track
at Scientific Sessions 2011

The American Heart Association's Interventional Cardiology Track (ICT) provides state of the art science for interventional cardiologists worldwide.  The primary goals of the track are to:
  1. select the best abstracts to highlight the stste of the interventional cardiology field in research;
  2. present and discuss the latest clinical trials that are changing our clinical practice;
  3. demonstrate the challenging art of interventional cardiology via case presentations, debates and discussions with a select group of international thought leaders.
Button_LearnMore

Scientific Sessions 2012

SS13-Generic_280x280